ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 282,96
-0,98%
DAX
18 691,32
0,05%
Brent Oil
81,025
-0,62%
Bitcoin
68 022,61
-1,56%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Tiziana Life Sciences Ltd (TLSA)

  7. Tiziana Life Sciences Ltd (TLSA) Actualités

TLSA

Tiziana Life Sciences (TLSA)

Tiziana Life Sciences Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TLSA
DateHeureSourceTitreSymboleSociété
13/05/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TLSATiziana Life Sciences Ltd
10/05/202423h00Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:TLSATiziana Life Sciences Ltd
01/09/202323h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TLSATiziana Life Sciences Ltd
15/08/202316h25AllPennyStocks.comBiotech Shares Experience Massive Premarket Buying PressureNASDAQ:TLSATiziana Life Sciences Ltd
13/06/202316h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
26/04/202320h37Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:TLSATiziana Life Sciences Ltd
13/04/202313h04InvestorsHub NewsWireTiziana Life Sciences to Pursue Development of Intranasal Foralumab for the Treatment of Long COVIDNASDAQ:TLSATiziana Life Sciences Ltd
31/03/202313h07InvestorsHub NewsWireTiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders ConferenceNASDAQ:TLSATiziana Life Sciences Ltd
27/12/202223h00GlobeNewswire Inc.Tiziana Life Sciences Ltd (“Tiziana” or “the Company”) - Interim Results for the Six Months Ended 30 June 2022NASDAQ:TLSATiziana Life Sciences Ltd
19/10/202213h00GlobeNewswire Inc.Tiziana Life Sciences Ltd Invites You to Join Us at The ThinkEquity ConferenceNASDAQ:TLSATiziana Life Sciences Ltd
12/10/202216h05AllPennyStocks.comBiotech Sees Premarket Buying Pressure Following IND ApplicationNASDAQ:TLSATiziana Life Sciences Ltd
21/09/202215h40TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:TLSATiziana Life Sciences Ltd
16/06/202218h36TipRanksB.Riley Financial Thinks Tiziana Life Sciences’ Stock is Going to RecoverNASDAQ:TLSATiziana Life Sciences Ltd
09/06/202218h25GlobeNewswire Inc.Tiziana Life Sciences Announces An Interview on Clinical Improvements for 2nd SPMS PatientNASDAQ:TLSATiziana Life Sciences Ltd
04/05/202222h35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TLSATiziana Life Sciences Ltd
29/04/202222h14Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NASDAQ:TLSATiziana Life Sciences Ltd
06/04/202215h45TipRanksB.Riley Financial Sticks to Their Buy Rating for Tiziana Life Sciences (TLSA)NASDAQ:TLSATiziana Life Sciences Ltd
11/03/202210h04TipRanksAnalysts Are Bullish on These Healthcare Stocks: Tiziana Life Sciences (TLSA)NASDAQ:TLSATiziana Life Sciences Ltd
10/03/202216h55TipRanksB.Riley Financial Keeps Their Buy Rating on Tiziana Life Sciences (TLSA)NASDAQ:TLSATiziana Life Sciences Ltd
04/03/202213h00GlobeNewswire Inc.AccuStem Sciences, Inc. Appoints New Executive Leadership TeamNASDAQ:TLSATiziana Life Sciences Ltd
25/02/202222h14Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:TLSATiziana Life Sciences Ltd
19/01/202215h08InvestorsHub NewsWireALYI - Underestimating The Potential Of Alternet Systems Could Be The Investment Blunder Of 2022...Here's WhyNASDAQ:TLSATiziana Life Sciences Ltd
21/10/202108h00GlobeNewswire Inc.Share Capital Consolidation and Commencement of trading in the New Tiziana Shares on NASDAQNASDAQ:TLSATiziana Life Sciences Ltd
20/10/202122h09Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:TLSATiziana Life Sciences Ltd
20/10/202115h40GlobeNewswire Inc.Tiziana Life Sciences - Scheme Effective DateNASDAQ:TLSATiziana Life Sciences Ltd
20/10/202108h00GlobeNewswire Inc.Tiziana Life Sciences plc: PDMR DealingNASDAQ:TLSATiziana Life Sciences Ltd
19/10/202115h26GlobeNewswire Inc.Tiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of CapitalNASDAQ:TLSATiziana Life Sciences Ltd
27/09/202118h39GlobeNewswire Inc.Tiziana Life Sciences Plc - Results of Court Meeting and General MeetingNASDAQ:TLSATiziana Life Sciences Ltd
24/09/202118h51GlobeNewswire Inc.Tiziana Life Sciences plc - Interim Results for the Six Months Ended 30 June 2021NASDAQ:TLSATiziana Life Sciences Ltd
07/09/202108h00GlobeNewswire Inc.Tiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer TreatmentNASDAQ:TLSATiziana Life Sciences Ltd
 Showing the most relevant articles for your search:NASDAQ:TLSA

Dernières Valeurs Consultées

BIT
P1UH66
NLBNPIT1UH66 20240621 2
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés